CG
LLY icon

Cynosure Group’s Eli Lilly LLY Stock Holding History

Cynosure Group’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-557
Closed -$599K – 347
2025
Q4 		$599K Sell
557
-804
-59% -$769K 0.06% 111
2025
Q3 		$1.04M Sell
1,361
-673
-33% -$501K 0.11% 72
2025
Q2 		$1.59M Buy
2,034
+367
+22% +$285K 0.18% 58
2025
Q1 		$1.38M Buy
1,667
+107
+7% +$89K 0.19% 57
2024
Q4 		$1.2M Sell
1,560
-562
-26% -$465K 0.18% 63
2024
Q3 		$1.88M Buy
2,122
+379
+22% +$341K 0.27% 47
2024
Q2 		$1.58M Buy
1,743
+16
+0.9% +$12.8K 0.25% 56
2024
Q1 		$1.34M Buy
1,727
+775
+81% +$552K 0.24% 49
2023
Q4 		$555K Buy
952
+64
+7% +$37.4K 0.1% 116
2023
Q3 		$477K Buy
+888
New +$458K 0.15% 111

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Cynosure Group's LLY Position: Q1 2026 in Review

Cynosure Group sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 557 shares — an estimated $599K sold.

Cynosure Group first reported a position in LLY in Q3 2023 and held it in 10 quarters. The position peaked at $1.88M in Q3 2024. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Cynosure Group reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
  • Cynosure Group sold 557 Eli Lilly shares in Q1 2026, an estimated $599K.
  • Cynosure Group first reported a position in Eli Lilly in Q3 2023 and held it in 10 quarters.
  • Cynosure Group's Eli Lilly position peaked at $1.88M in Q3 2024.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Cynosure Group's 13F filing for Q1 2026, filed 14 May 2026.